KR102051132B1 - 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물 - Google Patents

미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물 Download PDF

Info

Publication number
KR102051132B1
KR102051132B1 KR1020170033944A KR20170033944A KR102051132B1 KR 102051132 B1 KR102051132 B1 KR 102051132B1 KR 1020170033944 A KR1020170033944 A KR 1020170033944A KR 20170033944 A KR20170033944 A KR 20170033944A KR 102051132 B1 KR102051132 B1 KR 102051132B1
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
mirabegron
peo
present
controlled release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020170033944A
Other languages
English (en)
Korean (ko)
Other versions
KR20180106185A (ko
Inventor
김수연
김민수
서혜진
박신정
Original Assignee
주식회사 종근당
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 종근당 filed Critical 주식회사 종근당
Priority to KR1020170033944A priority Critical patent/KR102051132B1/ko
Priority to CN201880018616.8A priority patent/CN110446490B/zh
Priority to JP2019548680A priority patent/JP2020510679A/ja
Priority to PCT/KR2018/003043 priority patent/WO2018169325A1/ko
Publication of KR20180106185A publication Critical patent/KR20180106185A/ko
Application granted granted Critical
Publication of KR102051132B1 publication Critical patent/KR102051132B1/ko
Priority to JP2021123899A priority patent/JP2021185139A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
KR1020170033944A 2017-03-17 2017-03-17 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물 Active KR102051132B1 (ko)

Priority Applications (5)

Application Number Priority Date Filing Date Title
KR1020170033944A KR102051132B1 (ko) 2017-03-17 2017-03-17 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물
CN201880018616.8A CN110446490B (zh) 2017-03-17 2018-03-15 包含米拉贝隆或其盐的用于调节释放的药剂学组合物
JP2019548680A JP2020510679A (ja) 2017-03-17 2018-03-15 ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物
PCT/KR2018/003043 WO2018169325A1 (ko) 2017-03-17 2018-03-15 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물
JP2021123899A JP2021185139A (ja) 2017-03-17 2021-07-29 ミラベグロンまたはその塩を含む放出調節用薬剤学的組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170033944A KR102051132B1 (ko) 2017-03-17 2017-03-17 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물

Publications (2)

Publication Number Publication Date
KR20180106185A KR20180106185A (ko) 2018-10-01
KR102051132B1 true KR102051132B1 (ko) 2019-12-02

Family

ID=63522330

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020170033944A Active KR102051132B1 (ko) 2017-03-17 2017-03-17 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물

Country Status (4)

Country Link
JP (2) JP2020510679A (enrdf_load_stackoverflow)
KR (1) KR102051132B1 (enrdf_load_stackoverflow)
CN (1) CN110446490B (enrdf_load_stackoverflow)
WO (1) WO2018169325A1 (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210112240A (ko) 2020-03-03 2021-09-14 동광제약 주식회사 미라베그론을 포함하는 제어 방출 제제
KR20230026963A (ko) * 2021-08-18 2023-02-27 주식회사 삼양홀딩스 룩소리티닙의 경구용 정제 조성물 및 이의 제조 방법

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021069944A1 (en) * 2019-10-09 2021-04-15 Alvogen Korea Co., Ltd. Pharmaceutical composition comprising mirabegron and process for manufacturing the same
EP4338729A1 (en) 2022-09-19 2024-03-20 Sanovel Ilac Sanayi Ve Ticaret A.S. A tablet comprising mirabegron
KR20240102908A (ko) * 2022-12-26 2024-07-03 주식회사 렉스팜텍 아픽사반을 포함하는 서방성 정제
EP4410279A1 (en) 2023-01-25 2024-08-07 Sanovel Ilac Sanayi Ve Ticaret A.S. A film tablet comprising mirabegron

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101524164B1 (ko) * 2008-09-30 2015-06-01 아스텔라스세이야쿠 가부시키가이샤 방출 제어 의약 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA99407B (en) * 1998-01-22 1999-07-20 Abbott Lab Extended release tiagabine formulations with reduced side-effects.
RU2321401C2 (ru) * 2002-11-07 2008-04-10 Астеллас Фарма Инк. Лекарственное средство против гиперактивного мочевого пузыря, включающее производное анилида уксусной кислоты в качестве активного ингредиента
CA2550866A1 (en) * 2003-12-23 2005-07-14 Alza Corporation Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
SA07280459B1 (ar) * 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
WO2011122523A1 (ja) * 2010-03-29 2011-10-06 アステラス製薬株式会社 放出制御医薬組成物
JPWO2013147134A1 (ja) * 2012-03-30 2015-12-14 アステラス製薬株式会社 ミラベグロン含有医薬組成物
KR20150045500A (ko) * 2012-08-31 2015-04-28 아스텔라스세이야쿠 가부시키가이샤 경구 투여용 의약 조성물
CN104288116A (zh) * 2014-09-05 2015-01-21 南京华威医药科技开发有限公司 一种米拉贝隆缓释片组合物
KR20170088783A (ko) * 2017-07-07 2017-08-02 지엘팜텍주식회사 미라베그론의 습식과립 조성물
EP3292864A1 (en) * 2017-10-12 2018-03-14 Synthon B.V. Modified release tablet composition comprising mirabegron

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101524164B1 (ko) * 2008-09-30 2015-06-01 아스텔라스세이야쿠 가부시키가이샤 방출 제어 의약 조성물

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210112240A (ko) 2020-03-03 2021-09-14 동광제약 주식회사 미라베그론을 포함하는 제어 방출 제제
KR20230026963A (ko) * 2021-08-18 2023-02-27 주식회사 삼양홀딩스 룩소리티닙의 경구용 정제 조성물 및 이의 제조 방법
KR102794148B1 (ko) * 2021-08-18 2025-04-11 주식회사 삼양홀딩스 룩소리티닙의 경구용 정제 조성물 및 이의 제조 방법

Also Published As

Publication number Publication date
WO2018169325A1 (ko) 2018-09-20
JP2020510679A (ja) 2020-04-09
KR20180106185A (ko) 2018-10-01
CN110446490A (zh) 2019-11-12
CN110446490B (zh) 2023-04-04
JP2021185139A (ja) 2021-12-09

Similar Documents

Publication Publication Date Title
KR102051132B1 (ko) 미라베그론 또는 이의 염을 포함하는 방출조절용 약제학적 조성물
EP2200591A2 (en) Controlled release pharmaceutical dosage forms of trimetazidine
ES2281313T3 (es) Composiciones farmacéuticas que comprenden lercanidipino
KR102479497B1 (ko) 바레니클린 서방성 제제 및 이의 제조 방법
JP2012503613A (ja) コンパクト化シナカルセット
KR20150002453A (ko) 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제
CA2852417A1 (en) Sustained-release preparation
KR102062791B1 (ko) 미라베그론 또는 그의 약제학적으로 허용되는 염을 함유한 방출조절 제제
EP2377522B1 (en) Orally disintegrating tablet formulations of mirtazapine and process for preparing the same
EP2335698B1 (en) Pharmaceutical solid preparation having active ingredients separated by boundary therein
KR102206104B1 (ko) 실로도신을 포함하는 과립물, 및 이를 포함하는 약학적 조성물 및 제형
CA3190856A1 (en) Solid dosage forms of palbociclib
EP3697392B1 (en) Tablets comprising tamsulosin and solifenacin
JP2024067030A (ja) ミラベグロン含有放出制御医薬組成物及びその製造方法
EP3025707A1 (en) A multilayer tablet comprising metformin and pioglitazone
RU2616263C2 (ru) Таблетка с замедленным высвобождением, содержащая леводропропизин, и способ ее изготовления
JP2023071921A (ja) 様々な用量のレナリドミドの経口用錠剤組成物
EP2409685A2 (en) Orally-disintegrating formulations of prasugrel
EP2903593B1 (en) Tablet containing composite with cyclodextrin
CA2420712C (en) Fast release cefuroxime axetil compositions
JP2023035359A (ja) グアンファシン製剤
CA2520813C (en) Sustained release formulations of alkylene dioxybenzene derivatives useful as 5-ht1a agonists
TR202019592A2 (tr) Amorf dapagliflozinin katı farmasötik formülasyonları
WO2003075919A1 (fr) Comprime contenant du chlorhydrate de pilsicainide (voie seche)
EP3023094B1 (en) Novel formulation of cilostazol

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20170317

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20180122

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 20170317

Comment text: Patent Application

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20190507

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20191015

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20191126

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20191126

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20220920

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20230921

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20240919

Start annual number: 6

End annual number: 6